Experiment 1093686
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ROUTE NOT GIVEN |
| Organism | Mylabris phalerata (BRUCHIDAE) |
| Citation | WANG,GS:. (1980). ANTI-CANCER EFFECTS OF MYLABRIS AND ITS DEVELOPMENT.. 15(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | USED TO TREAT 800 CASES OF LIVER CANCER WITH A SURVIVAL RATE OF 12.7% AFTER 1 YEAR. THE DRUG SEEMS TO STABILIZE THE CONDITION AND PROLONG THE LIFE OF THE PATIENTS. SIDE EFFECTS WERE ENCOUNTERED FREQUENTLY AND INCLUDED DISORDERS OF THE URINARY SYSTEM,VOMITING,DIARRHEA,TACHYCARDIA AND NUMBNESS OF EXTREMITIES. THE OXIME DERIVATIVE OF CANTHARIDIN WAS PREPARED AND IT WAS TESTED IN 142 CASES OF LIVER CANCER, WITH AN EFFECTIVE RATE OF 56.3%. 51 PATIENTS SURVIVED AFTER 6 MONTHS. THIS DERIVATIVE IS LESS POTENT THAN CANTHARIDIN BUT IS MUCH LESS TOXIC. IT HAS BEEN USED SINCE 1977 IN CHINA. MORE THAN 250 CASES OF MALIGNANT TUMORS WERE TREATED WITH SODIUM SALT OF CANTHARIDIN WITH A SURVIVAL RATE OF 36% AFTER 6 MONTHS AND 15.5% AFTER 1 YEAR. IT HAS BEEN USED IN HUMANS SINCE 1978 IN CHINA. |
| Dose amount | VAR |
| Number | 4 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |